Genetic databases and their potential in pharmacogenomics

Current Pharmaceutical Design

Volumn 16, Issue 20, 2010, Pages 2224-2231

  Lagoumintzis, George ^a,b   Poulas, Konstantinos ^a   Patrinos, George P ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b TECHNOLOGICAL EDUCATIONAL INSTITUTE OF PATRAS   (Greece)

Author keywords

Databases; Mutations; Pharmacogenetics; Pharmacogenomics

Indexed keywords

ARTICLE; GENE MUTATION; GENETIC DATABASE; GENETIC VARIABILITY; PHARMACOGENOMICS; PRIORITY JOURNAL;

DATABASES, GENETIC; DRUG THERAPY; HUMANS; INDIVIDUALIZED MEDICINE; MUTATION; PHARMACOGENETICS; POLYMORPHISM, GENETIC;

EID: 77955616931     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161210791792804     Document Type: Article

References (38)

1. McKusick VA. Mendelian inheritance in man. A catalog of human genes and genetic disorders. 1st ed. Baltimore, MD: Johns Hopkins University Press 1966.
2. Hamosh A, Scott AF, Amberger J, et al. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res 2005; 33: D514-D517.
3. Hardison RC, Chui DH, Giardine B, et al. HbVar: A relational database of human hemoglobin variants and thalassemia mutations at the globin gene server. Hum Mutat 2002; 19: 225-33.
4. Patrinos GP, Giardine B, Riemer C, et al. Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies. Nucleic Acids Res 2004; 32: D537-D541.
5. Cotton RG, McKusick V, Scriver CR. The HUGO Mutation Database Initiative. Science 1998; 279: 10-11.
6. Stenson PD, Ball EV, Mort M, et al. Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat 2003; 21: 577-81.
7. George RA, Smith TD, Callaghan S, et al. General mutation databases: analysis and review. J Med Genet 2008; 45: 65-70.
8. Claustres M, Horaitis O, Vanevski M, et al. Time for a unified system of mutation description and reporting: a review of locusspecific mutation databases. Genome Res 2002; 12: 680-88.
9. Cotton RG, Phillips K, Horaitis O. A survey of locus-specific database curation. Human genome variation society. J Med Genet 2007; 44: e72.
10. Patrinos GP. National and Ethnic mutation databases: recording populations' genography. Hum Mutat 2006; 27: 879-87.
11. Wheeler DL, Barrett T, Benson DA, et al. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 2008; 36: D13-D21.
12. Thorisson GA, Lancaster O, Free RC, et al. HGVbaseG2P: a central genetic association database. Nucleic Acids Res 2009; 37: D797-D802.
13. Klein TE, Chang JT, Cho MK, et al. Integrating genotype and phenotype information: an overview of the PharmGKB project. Pharmacogenetics research network and knowledge base. Pharmacogenomics J 2001; 1(3): 167-70.
14. Davis A, Long R. Pharmacogenetics research network and knowledge base: 1st annual scientific meeting. Pharmacogenomics 2001; 2(3): 285-9.
15. Thorn CF, Klein TE, Altman RB. PharmGKB: the pharmacogenetics and pharmacogenomics knowledge base. Methods Mol Biol 2005; 311: 179-91.
16. Owen RP, Altman RB, Klein TE. PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single-drug pharmacogenetics. Hum Mutat 2008; 29(4): 456-60.
17. International Warfarin Pharmacogenetics Consortium. Estimation of the warfarin dose with clinical and pharmacogenetic data. N Engl J Med 2009; 360(8): 753-64.
18. Wain HM, Lush MJ, Ducluzeau F, et al. Genew: the human gene nomenclature database, 2004 updates. Nucleic Acids Res 2004; 32: D255-7.
19. Tate SK, Golstein DB. Will tomorrow's medicines work for everyone? Nat Genet, 2004; 36: S34-42.
20. Sangkuhl K, Berlin DS, Altman RB, et al. PharmGKB: understanding the effects of individual genetic variants. Drug Metab Rev 2008; 40(4): 539-51.
21. Sipila K, Aula P. Database for the mutations of the finnish disease heritage. Hum Mutat 2002; 19: 16-22.
22. Patrinos GP, van Baal S, Petersen MB, et al. The hellenic national mutation database: a prototype database for mutations leading to inherited disorders in the hellenic population. Hum Mutat 2005; 25: 327-33.
23. Kleanthous M, Patsalis PC, Drousiotou A, et al. The cypriot and Iranian national mutation databases. Hum Mutat 2006; 27: 598-99.
24. Patrinos GP, Kollia P, Papadakis MN. Molecular diagnosis of inherited disorders: lessons from hemoglobinopathies. Hum Mutat 2005; 26: 399-412.
25. van Baal S, Kaimakis P, Phommarinh M, et al. FINDbase: A relational database recording frequencies of genetic defects leading to inherited disorders worldwide. Nucleic Acids Res 2007; 35: D690- 5.
26. Patrinos GP, Brookes AJ. DNA, disease and databases: disastrously deficient. Trends Genet 2005; 21: 333-8.
27. Zheng CJ, Han LY, Xie B, et al. PharmGED: pharmacogenetic effect database. Nucleic Acids Res 2007; 35: D794-9.
28. Stein L. Creating a bioinformatics nation. Nature 2002; 417: 119- 20.
29. Ring HZ, Kwok PY, Cotton RG. Human Variome Project: an international collaboration to catalogue human genetic variation. Pharmacogenomics 2006; 7: 969-72.
30. Horaitis O, Talbot CC, Jr, Phommarinh M, et al. A database of locus-specific databases. Nat Genet 2007; 39: 425.
31. Kaput J, Cotton RG, Hardman L, et al. Planning the human variome project. The Spain report. Hum Mutat 2009; 30: 496-510.
32. Patrinos GP, Wajcman H. Recording human globin gene variation. Hemoglobin 2004; 28(2): v-vii.
33. Axton M. Human Variome microattribution reviews. Nat Genet 2008; 40: 1.
34. Patrinos GP, Petricoin EF. A new scientific journal linked to a genetic database: Towards a novel publication modality. Hum Genomics Proteomics 2009; 1: e597478.
35. Perera M, Innocenti F. Pharmacogenetics and pharmacogenomicsl impact on drug discovery and clinical care. In: Patrinos GP, Ansorge W, Eds. Molecular Diagnostics. 2nd ed. USA: Academic Press 2010; pp. 327-345.
36. Akkari PA, Swanson T W, Crenshaw DG, et al. Pipeline pharmacogenetics: a novel approach to integrating pharmaco-genetics into drug development. Curr Pharm Des 2009; 15(32): 3754-63.
37. Raaijmakers JA, Koster ES, Maitland-van der Zee AH. Pharmacogenetics and the pharmaceutical industry. Curr Pharm Des 2010; 16(2): 238-44.
38. Raby BA. Genetic mapping of pharmacogenetic regulatory variation. Curr Pharm Des 2009; 15(32): 3773-81.